LICENSE AND RESEARCH AGREEMENT BETWEEN ANTIGEN EXPRESS, INC. (A WHOLLY-OWNED SUBSIDIARY OF GENEREX BIOTECHNOLOGY CORPORATION) AND SHENZHEN BIOSCIEN PHARMACEUTICALS CO. LTD. November 29th, 2017License and Research Agreement • December 12th, 2017 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
This License and Research Agreement (the "Agreement"), effective as of the day of November, 2017 (the "Effective Date"), is by and between Antigen Express, Inc., a wholly-owned subsidiary of Generex Biotechnology Corporation, a Delaware corporation, with an address of 4145 North Service Road, Suite 200, Burlington, Ontario, Canada L7L 6A3 (hereinafter referred as "Licensor"), and Shenzhen BioScien Pharmaceuticals Co., Ltd., located at Room 311, First Building, Shenzhen Overseas Venture Park (Longgang), Shenzhen 518116, Guangdong, China (hereinafter referred to as "Licensee"). Licensor and Licensee may each be referred to herein individually as a "Party" and collectively
